Immunosuppressive agents for treating IgA nephropathy

BACKGROUND: IgA nephropathy is the most common glomerulonephritis world‐wide. IgA nephropathy causes end‐stage kidney disease (ESKD) in 15% to 20% of affected patients within 10 years and in 30% to 40% of patients within 20 years from the onset of disease. This is an update of a Cochrane review firs...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cochrane Database Syst Rev
Main Authors: Natale, Patrizia, Palmer, Suetonia C, Ruospo, Marinella, Saglimbene, Valeria M, Craig, Jonathan C, Vecchio, Mariacristina, Samuels, Joshua A, Molony, Donald A, Schena, Francesco Paolo, Strippoli, Giovanni FM
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Ltd 2020
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7066485/
https://ncbi.nlm.nih.gov/pubmed/32162319
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD003965.pub3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados